CD22-directed Immunoconjugate [EPC] - N0000193617

Pharmacologic Code	N0000193617
Pharmacologic Name	CD22-directed Immunoconjugate
Pharmacologic Uses	CD22-directed antibody-drug conjugate (ADC)
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD22-directed Immunoconjugate [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0008-0100	Besponsa	Non-Proprietary Name: Inotuzumab Ozogamicin	Injection, Powder, Lyophilized, For Solution	Intravenous	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	ACTIVE